Industry Growth Insights published a new data on “Preimplantation Genetic Screening Market”. The research report is titled “Preimplantation Genetic Screening Market research by Types (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Single Nucleotide Polymorphism (SNP)), By Applications (Single Gene Disorders, X-linked Disorders, HLA Typing, Gender Identification), By Players/Companies Illumina, Inc (US), Thermo Fisher Scientific Inc (US), Agilent Technologies, Inc (US), PerkinElmer, Inc (US), CooperSurgical, Inc (US), Beijing Genomics Institute (BGI) (China)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Preimplantation Genetic Screening Market Research Report
By Type
Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Single Nucleotide Polymorphism (SNP)
By Application
Single Gene Disorders, X-linked Disorders, HLA Typing, Gender Identification
By Companies
Illumina, Inc (US), Thermo Fisher Scientific Inc (US), Agilent Technologies, Inc (US), PerkinElmer, Inc (US), CooperSurgical, Inc (US), Beijing Genomics Institute (BGI) (China)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
120
Number of Tables & Figures
84
Customization Available
Yes, the report can be customized as per your need.
Global Preimplantation Genetic Screening Market Report Segments:
The global Preimplantation Genetic Screening market is segmented on the basis of:
Types
Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Single Nucleotide Polymorphism (SNP)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Single Gene Disorders, X-linked Disorders, HLA Typing, Gender Identification
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina, Inc (US)
- Thermo Fisher Scientific Inc (US)
- Agilent Technologies, Inc (US)
- PerkinElmer, Inc (US)
- CooperSurgical, Inc (US)
- Beijing Genomics Institute (BGI) (China)
Highlights of The Preimplantation Genetic Screening Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescent In-situ Hybridization (FISH)
- Comparative Genomic Hybridization (CGH)
- Single Nucleotide Polymorphism (SNP)
- By Application:
- Single Gene Disorders
- X-linked Disorders
- HLA Typing
- Gender Identification
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Preimplantation Genetic Screening Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Preimplantation genetic screening (PGS) is a procedure that can be used to screen embryos for genetic disorders. PGS is performed before fertilization in order to identify embryos with potential problems.
Some of the key players operating in the preimplantation genetic screening market are Illumina, Inc (US), Thermo Fisher Scientific Inc (US), Agilent Technologies, Inc (US), PerkinElmer, Inc (US), CooperSurgical, Inc (US), Beijing Genomics Institute (BGI) (China).
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Preimplantation Genetic Screening Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Preimplantation Genetic Screening Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Preimplantation Genetic Screening Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Preimplantation Genetic Screening Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Preimplantation Genetic Screening Market Size & Forecast, 2018-2028 4.5.1 Preimplantation Genetic Screening Market Size and Y-o-Y Growth 4.5.2 Preimplantation Genetic Screening Market Absolute $ Opportunity
Chapter 5 Global Preimplantation Genetic Screening Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Preimplantation Genetic Screening Market Size Forecast by Type
5.2.1 Next Generation Sequencing (NGS)
5.2.2 Polymerase Chain Reaction (PCR)
5.2.3 Fluorescent In-situ Hybridization (FISH)
5.2.4 Comparative Genomic Hybridization (CGH)
5.2.5 Single Nucleotide Polymorphism (SNP)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Preimplantation Genetic Screening Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Preimplantation Genetic Screening Market Size Forecast by Applications
6.2.1 Single Gene Disorders
6.2.2 X-linked Disorders
6.2.3 HLA Typing
6.2.4 Gender Identification
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Preimplantation Genetic Screening Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Preimplantation Genetic Screening Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Preimplantation Genetic Screening Analysis and Forecast
9.1 Introduction
9.2 North America Preimplantation Genetic Screening Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Preimplantation Genetic Screening Market Size Forecast by Type
9.6.1 Next Generation Sequencing (NGS)
9.6.2 Polymerase Chain Reaction (PCR)
9.6.3 Fluorescent In-situ Hybridization (FISH)
9.6.4 Comparative Genomic Hybridization (CGH)
9.6.5 Single Nucleotide Polymorphism (SNP)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Preimplantation Genetic Screening Market Size Forecast by Applications
9.10.1 Single Gene Disorders
9.10.2 X-linked Disorders
9.10.3 HLA Typing
9.10.4 Gender Identification
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Preimplantation Genetic Screening Analysis and Forecast
10.1 Introduction
10.2 Europe Preimplantation Genetic Screening Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Preimplantation Genetic Screening Market Size Forecast by Type
10.6.1 Next Generation Sequencing (NGS)
10.6.2 Polymerase Chain Reaction (PCR)
10.6.3 Fluorescent In-situ Hybridization (FISH)
10.6.4 Comparative Genomic Hybridization (CGH)
10.6.5 Single Nucleotide Polymorphism (SNP)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Preimplantation Genetic Screening Market Size Forecast by Applications
10.10.1 Single Gene Disorders
10.10.2 X-linked Disorders
10.10.3 HLA Typing
10.10.4 Gender Identification
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Preimplantation Genetic Screening Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Preimplantation Genetic Screening Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Preimplantation Genetic Screening Market Size Forecast by Type
11.6.1 Next Generation Sequencing (NGS)
11.6.2 Polymerase Chain Reaction (PCR)
11.6.3 Fluorescent In-situ Hybridization (FISH)
11.6.4 Comparative Genomic Hybridization (CGH)
11.6.5 Single Nucleotide Polymorphism (SNP)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Preimplantation Genetic Screening Market Size Forecast by Applications
11.10.1 Single Gene Disorders
11.10.2 X-linked Disorders
11.10.3 HLA Typing
11.10.4 Gender Identification
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Preimplantation Genetic Screening Analysis and Forecast
12.1 Introduction
12.2 Latin America Preimplantation Genetic Screening Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Preimplantation Genetic Screening Market Size Forecast by Type
12.6.1 Next Generation Sequencing (NGS)
12.6.2 Polymerase Chain Reaction (PCR)
12.6.3 Fluorescent In-situ Hybridization (FISH)
12.6.4 Comparative Genomic Hybridization (CGH)
12.6.5 Single Nucleotide Polymorphism (SNP)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Preimplantation Genetic Screening Market Size Forecast by Applications
12.10.1 Single Gene Disorders
12.10.2 X-linked Disorders
12.10.3 HLA Typing
12.10.4 Gender Identification
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Preimplantation Genetic Screening Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Preimplantation Genetic Screening Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Preimplantation Genetic Screening Market Size Forecast by Type
13.6.1 Next Generation Sequencing (NGS)
13.6.2 Polymerase Chain Reaction (PCR)
13.6.3 Fluorescent In-situ Hybridization (FISH)
13.6.4 Comparative Genomic Hybridization (CGH)
13.6.5 Single Nucleotide Polymorphism (SNP)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Preimplantation Genetic Screening Market Size Forecast by Applications
13.10.1 Single Gene Disorders
13.10.2 X-linked Disorders
13.10.3 HLA Typing
13.10.4 Gender Identification
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Preimplantation Genetic Screening Market: Competitive Dashboard
14.2 Global Preimplantation Genetic Screening Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Illumina, Inc (US)
14.3.2 Thermo Fisher Scientific Inc (US)
14.3.3 Agilent Technologies, Inc (US)
14.3.4 PerkinElmer, Inc (US)
14.3.5 CooperSurgical, Inc (US)
14.3.6 Beijing Genomics Institute (BGI) (China)